A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

Background: The novel biologic agent ustekinumab (UST), a monoclonal antibody against the p40 subunit of interleukin-12 and interleukin-23, has been applied in the treatment of Crohn’s disease (CD). With the development of relevant research, the clinical treatment and favorable prognosis of UST in C...

Full description

Bibliographic Details
Main Authors: Yi Chen, Jiaqi Zhang, Junling Wu, Hanwen Zhang, Zhe Luan, Zhizhuang Zhao, Congyong Li, Yiming Zhao, Hu Zhang, Shufang Wang, Gang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
ustekinumab
Crohn’s disease
bibliometric analysis
biomarker
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1322319/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1322319/full

Similar Items